At last years BioPharma India conference Shekar Ganesa, Senior Director, Analytical Development, Genzyme-Sanofi delivered the presentation: Analytical Considerations for Biopharmaceuticals and its Implications for Biosimilars.
This presenation explores:
â¢ Complexity of Biologics
â¢ FDA Draft Guidance on Biosimilars
â¢ Comparability – What does that mean?
â¢ Examples and Analytical Methods Used to monitor PTM's
â¢ Emerging Technologies
If you found this presentation interesting then you may also be interested in our BioPharma India 2013 event. Click here to visit the event website